11-62615729-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_012200.4(B3GAT3):c.980G>A(p.Arg327Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000049 in 1,613,746 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_012200.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
B3GAT3 | NM_012200.4 | c.980G>A | p.Arg327Gln | missense_variant | 5/5 | ENST00000265471.10 | NP_036332.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
B3GAT3 | ENST00000265471.10 | c.980G>A | p.Arg327Gln | missense_variant | 5/5 | 1 | NM_012200.4 | ENSP00000265471.5 | ||
B3GAT3 | ENST00000532585.5 | n.*1102G>A | non_coding_transcript_exon_variant | 6/6 | 1 | ENSP00000432604.1 | ||||
B3GAT3 | ENST00000532585.5 | n.*1102G>A | 3_prime_UTR_variant | 6/6 | 1 | ENSP00000432604.1 | ||||
B3GAT3 | ENST00000531383 | c.*457G>A | 3_prime_UTR_variant | 5/5 | 2 | ENSP00000431359.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152246Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000400 AC: 10AN: 250072Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135402
GnomAD4 exome AF: 0.0000534 AC: 78AN: 1461500Hom.: 0 Cov.: 31 AF XY: 0.0000550 AC XY: 40AN XY: 727050
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152246Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74376
ClinVar
Submissions by phenotype
Larsen-like syndrome, B3GAT3 type Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Baylor Genetics | Apr 14, 2023 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 31, 2022 | This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 327 of the B3GAT3 protein (p.Arg327Gln). This variant is present in population databases (rs569989507, gnomAD 0.009%). This variant has not been reported in the literature in individuals affected with B3GAT3-related conditions. ClinVar contains an entry for this variant (Variation ID: 1029180). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The glutamine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Apr 12, 2021 | Not observed at a significant frequency in large population cohorts (Lek et al., 2016); In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at